This section hosts guidelines, manuals and toolkits to strengthen public health practice.
View All
The safety of authorized COVID-19 vaccines is continuously monitored, and updated information is regularly provided to the public. Safety updates outline the outcomes from assessments of emerging worldwide safety data carried out mainly by EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) (section 1). They also outline how safety is monitored and contain high-level information on suspected adverse reaction reports, which PRAC takes into account in its assessments (section 2). This safety update follows the update of 17 February 2022 and reflects the main assessment outcomes of the PRAC meetings held 7 to 10 March 2022. EMA confirms that the benefits of all currently authorized COVID-19 vaccines continue to outweigh their side effects, given the risk of COVID-19 illness and related complications, including hospitalization and death.
Categories
COVID-19